Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer
Takashi Hirose, Takao Shirai, Hiroo Ishida, Kohichi Ando, Tomohide Sugiyama, Sojiro Kusumoto, Takamichi Hosaka, Masanao Nakashima, Tohru Ohmori, Mitsuru AdachiТом:
60
Мова:
english
Сторінки:
8
DOI:
10.1007/s00280-006-0369-4
Date:
July, 2007
Файл:
PDF, 312 KB
english, 2007